Vascodagama Online Journal

Heart failure Pipeline: Emerging Therapies and Key pharma players involved by DelveInsight | Bayer, Amgen, Juventas Therapeutics, GlaxoSmithKline and Many Others

 Breaking News
  • No posts were found

Heart failure Pipeline: Emerging Therapies and Key pharma players involved by DelveInsight | Bayer, Amgen, Juventas Therapeutics, GlaxoSmithKline and Many Others

June 15
15:29 2021
Heart failure Pipeline: Emerging Therapies and Key pharma players involved by DelveInsight | Bayer, Amgen, Juventas Therapeutics, GlaxoSmithKline and Many Others

Heart failure Pipeline

Heart failure, also known as congestive heart failure refers to the condition when heart is not able to pump adequate blood to the body. In the absence of sufficient blood flow, all the major body functions are disrupted. Certain conditions, such as narrowed arteries in the heart (coronary artery disease) or high blood pressure, gradually leave the heart too weak or stiff to fill and pump efficiently. Heart failure can be diagnosed based on the medical and family history, a physical exam, and test results. Treating heart failure depends on the severity of the condition. Diagnostic tests include: electrocardiogram, chest X-Ray, echocardiography etc. Treatments usually include heart-healthy lifestyle changes, medicines, and ongoing care.

DelveInsight’s, “Heart failure Pipeline Insight, 2021” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Heart failure pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

 

Request for Free Sample Report: https://www.delveinsight.com/sample-request/heart-failure-pipeline-insight

 

Heart failure Key Players:

  • Bayer
  • Amgen
  • Juventas Therapeutics
  • GlaxoSmithKline
  • Lantheus Medical Imaging
  • And Many Others

 

DelveInsight’s Heart failure report covers around 10+ products under different phases of clinical development like:

  • Late-stage products (Phase III)
  • Mid-stage products (Phase II and Phase I/II)
  • Early-stage products (Phase I/II and Phase I) along with the details of
  • Pre-clinical and Discovery stage candidates
  • Discontinued & Inactive candidates

 

Request for Free Sample Report: https://www.delveinsight.com/sample-request/heart-failure-pipeline-insight

 

Some of Heart failure Therapies:

  • BAY-1753011
  • Omecamtiv Mecarbil
  • ACRX-100
  • GSK2798745
  • LMI 1195-101
  • And Many Others

 

Current Heart failure Treatment Scenario and Heart failure Emerging Therapies:

  • How many companies are developing Heart failure drugs?
  • How many Heart failure drugs are developed by each company?
  • How many emerging drugs are in mid-stage, and late-stage of development for the treatment of Heart failure?
  • What are the key collaborations (Industry–Industry, Industry–Academia), Mergers and acquisitions, licensing activities related to the Heart failure therapeutics?
  • What are the recent trends, drug types and novel technologies developed to overcome the limitation of existing therapies?
  • What are the clinical studies going on for Heart failure and their status?
  • What are the key designations that have been granted to the emerging drugs?

 

Request for Free Sample Report: https://www.delveinsight.com/sample-request/heart-failure-pipeline-insight

 

Table of Contents:

Introduction

Executive Summary

Heart failure: Overview

Pipeline Therapeutics

• Comparative Analysis

Therapeutic Assessment

Heart failure – DelveInsight’s Analytical Perspective

In-depth Commercial Assessment

Heart failure Collaboration Deals

Late Stage Products (Phase III)

• Comparative Analysis

Omecamtiv Mecarbil: Amgen

Drug profiles in the detailed report…..

Mid Stage Products (Phase II)

• Comparative Analysis

Pecavaptan: Bayer

Drug profiles in the detailed report…..

Pre-clinical and Discovery Stage Products

Drug profiles in the detailed report…..

Inactive Products

• Comparative Analysis

Heart failure Key Companies

Heart failure Key Products

Heart failure- Unmet Needs

Heart failure- Market Drivers and Barriers

Heart failure- Future Perspectives and Conclusion

Heart failure Analyst Views

Heart failure Key Companies

Appendix

Request for Detailed TOC: https://www.delveinsight.com/sample-request/heart-failure-pipeline-insight

 

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end-to-end comprehensive solutions to improve their performance.  Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: +19193216187
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/report-store/heart-failure-pipeline-insight